417 related articles for article (PubMed ID: 20482618)
1. Organ transplantation and skin cancer: basic problems and new perspectives.
Hofbauer GF; Bouwes Bavinck JN; Euvrard S
Exp Dermatol; 2010 Jun; 19(6):473-82. PubMed ID: 20482618
[TBL] [Abstract][Full Text] [Related]
2. The role of sirolimus in the prevention of cutaneous squamous cell carcinoma in organ transplant recipients.
Leblanc KG; Hughes MP; Sheehan DJ
Dermatol Surg; 2011 Jun; 37(6):744-9. PubMed ID: 21605234
[TBL] [Abstract][Full Text] [Related]
3. Systemic strategies for chemoprevention of skin cancers in transplant recipients.
Kovach BT; Sams HH; Stasko T
Clin Transplant; 2005 Dec; 19(6):726-34. PubMed ID: 16313317
[TBL] [Abstract][Full Text] [Related]
4. [Skin cancer and other skin disorders in patients following solid organ transplantation].
de Graaf YG; de Fijter JW; Posma AN; Feltkamp MC; Claas FH; Bouwes Bavinck JN
Ned Tijdschr Geneeskd; 2005 Mar; 149(10):511-7. PubMed ID: 15782685
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppression affects CD4+ mRNA expression and induces Th2 dominance in the microenvironment of cutaneous squamous cell carcinoma in organ transplant recipients.
Kosmidis M; Dziunycz P; Suárez-Fariñas M; Mühleisen B; Schärer L; Läuchli S; Hafner J; French LE; Schmidt-Weber C; Carucci JA; Hofbauer GF
J Immunother; 2010 Jun; 33(5):538-46. PubMed ID: 20463594
[TBL] [Abstract][Full Text] [Related]
6. Squamous cell carcinoma in solid-organ transplantation.
Wu JJ; Orengo IF
Dermatol Online J; 2002 Oct; 8(2):4. PubMed ID: 12546759
[TBL] [Abstract][Full Text] [Related]
7. Papillomavirus-associated squamous skin cancers following transplant immunosuppression: one Notch closer to control.
Connolly K; Manders P; Earls P; Epstein RJ
Cancer Treat Rev; 2014 Mar; 40(2):205-14. PubMed ID: 24051018
[TBL] [Abstract][Full Text] [Related]
8. The relative effects of different systemic immunosuppressives on skin cancer development in organ transplant patients.
Durando B; Reichel J
Dermatol Ther; 2005; 18(1):1-11. PubMed ID: 15842607
[TBL] [Abstract][Full Text] [Related]
9. Keratinocyte cancer and its precursors in organ transplant patients.
Jenni D; Hofbauer GF
Curr Probl Dermatol; 2015; 46():49-57. PubMed ID: 25561206
[TBL] [Abstract][Full Text] [Related]
10. Histologic features in primary cutaneous squamous cell carcinomas in immunocompromised patients focusing on organ transplant patients.
Smith KJ; Hamza S; Skelton H
Dermatol Surg; 2004 Apr; 30(4 Pt 2):634-41. PubMed ID: 15061848
[TBL] [Abstract][Full Text] [Related]
11. [Organ transplant recipients need intensive control and treatment of skin cancer].
Togsverd-Bo K; Sørensen SS; Hædersdal M
Ugeskr Laeger; 2013 May; 175(20):1408-11. PubMed ID: 23663395
[TBL] [Abstract][Full Text] [Related]
12. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study.
Ulrich C; Jürgensen JS; Degen A; Hackethal M; Ulrich M; Patel MJ; Eberle J; Terhorst D; Sterry W; Stockfleth E
Br J Dermatol; 2009 Nov; 161 Suppl 3():78-84. PubMed ID: 19775361
[TBL] [Abstract][Full Text] [Related]
13. Management of non-melanoma skin cancer in solid organ transplant recipients.
Specchio F; Saraceno R; Chimenti S; Nistico S
Int J Immunopathol Pharmacol; 2014; 27(1):21-4. PubMed ID: 24674675
[TBL] [Abstract][Full Text] [Related]
14. Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients.
Ulrich C; Schmook T; Sachse MM; Sterry W; Stockfleth E
Dermatol Surg; 2004 Apr; 30(4 Pt 2):622-7. PubMed ID: 15061846
[TBL] [Abstract][Full Text] [Related]
15. Skin cancer in liver transplant recipients.
Otley CC; Pittelkow MR
Liver Transpl; 2000 May; 6(3):253-62. PubMed ID: 10827224
[TBL] [Abstract][Full Text] [Related]
16. Sun protection attitudes and behaviors of solid-organ transplant recipients.
Robinson JK; Rigel DS
Dermatol Surg; 2004 Apr; 30(4 Pt 2):610-5. PubMed ID: 15061844
[TBL] [Abstract][Full Text] [Related]
17. [Great risk of skin cancer in patients with transplanted organs. Sun is the most dangerous enemy].
Lindelöf B; Gäbel H
Lakartidningen; 2000 Oct; 97(43):4822-4. PubMed ID: 11085025
[No Abstract] [Full Text] [Related]
18. [Immunosuppressive drugs and the development of skin cancer after organ transplantation].
Gjersvik P; Helsing P; Holdaas H; Bergan S
Tidsskr Nor Laegeforen; 2012 Oct; 132(18):2064-8. PubMed ID: 23038197
[TBL] [Abstract][Full Text] [Related]
19. No association between infections, HLA type and other transplant-related factors and risk of cutaneous squamous cell carcinoma in solid organ transplant recipients.
Ingvar Å; Ekström Smedby K; Lindelöf B; Fernberg P; Bellocco R; Tufveson G; Höglund P; Adami J
Acta Derm Venereol; 2012 Nov; 92(6):609-14. PubMed ID: 22293782
[TBL] [Abstract][Full Text] [Related]
20. Skin lesions in adult liver transplant recipients: a study of 100 consecutive patients.
Perera GK; Child FJ; Heaton N; O'Grady J; Higgins EM
Br J Dermatol; 2006 May; 154(5):868-72. PubMed ID: 16634888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
